Observations on a “sentinel node” in cancer of the parotid

Gould, Ernest A.; Winship, Theodore; Philbin, Philip H.; Kerr, Harry Hyland

doi:10.1002/1097-0142(196001/02)13:1<77::aid-cncr2820130114>3.0.co;2-d

Cited by 386 publications

(184 citation statements)

References 3 publications

Supporting

Mentioning

152

Contrasting

Unclassified

Order By: Relevance

“…Gould et al 63 first used the term sentinel lymph node in 1960 to describe a lymph node that was the first to drain the parotid gland. In 1977, Cabanas et al 64 were the first to describe a technique for lymphatic mapping (specifically, lymphography of the penis).…”

Section: Lymphatic Mappingmentioning

confidence: 99%

Imaging in cervical cancer

Follen

Levenback

Iyer

et al. 2003

Cancer

125

View full text Add to dashboard Cite

show abstract

Section: Lymphatic Mappingmentioning

confidence: 99%

Imaging in cervical cancer

Follen

Levenback

Iyer

et al. 2003

Cancer

125

View full text Add to dashboard Cite

show abstract

“…First described in the 1960s and 1970s for parotid cancer 1 and penile cancer 2 , the concept was applied as a method of staging cutaneous melanoma by Morton et al 3,4 . They demonstrated that the status of sentinel nodes, with respect to the presence of metastases, accurately reflected the metastatic content of the local nodal basin 5 .…”

Section: Introductionmentioning

confidence: 99%

Sentinel lymph node biopsy in early breast cancer surgery – Working with the risks of vital blue dye to reap the benefits

White

Harvey

Griffith

et al. 2011

European Journal of Surgical Oncology (EJSO)

View full text Add to dashboard Cite

“…Gould in 1960 and supplemented then by R.M. Cabanas in 1977 [3,4]. The concept of sentinel lymph node (SLN) is based on the theory of an orderly progression of tumor cells within the lymphatic system in the initial phase of the metastatic process, assuming that early lymphatic metastases are found first within the first-line tumor draining lymph node, the sentinel lymph node [4].…”

Section: Introductionmentioning

confidence: 99%

The first experience of using 99mTc-Al2O3-based radiopharmaceutical for the detection of sentinel lymph nodes in cervical cancer patients

Синилкин¹,

Chernov²,

Lyapunov

et al. 2016

AIP Conference Proceedings

View full text Add to dashboard Cite

Abstract. The purpose of the study was to evaluate the feasibility of using 99m Tc-Al 2 O 3 -based radiopharmaceutical, a novel molecular imaging agent for sentinel lymph node detection in patients with invasive cervical cancer. The study included 23 cervical cancer patients (T1aN M -T2bN M ) treated at the Tomsk Cancer Research Institute. In the 18 hours before surgery, 80 MBq of the 99m Tc-Al 2 O 3 in peritumoral injected, followed by single-photon emission computed tomography (SPECT) of the pelvis and intraoperative SLN identification. Twenty-seven SLNs were detected by SPECT, and 34 SLNs were identified by intraoperative gamma probe. The total number of identified SLNs per patient ranged from 1 to 3 (the mean number of SLNs was 1.4 per patient). The most common site for SLN detection was the external iliac region (57.2%), followed by the internal iliac (14%), obturator (14%), presacral and retrosacral regions (14%), and the parametrial region (1%). Sensitivity in detecting SLNs was 100% for intraoperative SLN identification and 79% for SPECT image.

show abstract

Observations on a “sentinel node” in cancer of the parotid

Cited by 386 publications

References 3 publications

Imaging in cervical cancer

Imaging in cervical cancer

Sentinel lymph node biopsy in early breast cancer surgery – Working with the risks of vital blue dye to reap the benefits

The first experience of using 99mTc-Al2O3-based radiopharmaceutical for the detection of sentinel lymph nodes in cervical cancer patients

Contact Info

Product

Resources

About